10 results
Antibiogram - Antibiotic Resistance Table for Severe Multidrug Resistant Bacteria

ESBL Enterobacteriaceae
Carbapenem-Resistant Enterobacteriaceae
MDR Pseudomonas Aeruginosa
Carbapenem-Resistant Acinetobacter

Adapted from
Antibiogram - Antibiotic ... ABsteward #MDR #Antibiogram ... #Antibiotic #Resistance ... InfectiousDiseases #Resistant #Comparison ... #Table #Pharmacology
Parenteral Antimicrobial Treatment of Common Microorganisms Causing Native Vertebral Osteomyelitis - IDSA 
Staphylococci, oxacillin susceptible
Staphylococci, oxacillin
Osteomyelitis - IDSA ... #Parenteral #IV ... #Antibiotics #Osteomyelitis ... management #treatment #pharmacology ... #idsa
IV Fluids - Comparison Table
Fluid - pH - Osm - Na - Cl - Other
 •
IV Fluids - Comparison ... pH - Osm - Na - Cl ... EmmGeezee #IV ... #Fluids #IVF #Comparison ... #Table #pharmacology
Intern Pocket Cards - Antibiogram and Susceptibilities
VRE - MRSA - GRAM POSITIVES - GRAM NEGATIVES -
Pocket Cards - Antibiogram ... (IV or PO?) ... If on IV, can I ... Susceptibilities #antibiotics ... #management #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... PO (or 400 mg IV ... if MIC<0.12 ug/ml ... Enteric #Bacterial #IDSA ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... 100 cells/mm3 g/mL ... to 5 mg/kg/day IV ... Penicilliosis #IDSA ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... suspension 4–6 mL ... 400 mg) PO or IV ... candida #mucosal #IDSA ... infections #HIVAIDS #pharmacology
Antimicrobial Regimens for Acute Bacterial Rhinosinusitis in Adults
Initial empirical therapy: 
 • Amoxicillin-clavulanate (500 mg/125 mg
qd) Risk for antibiotic ... (500 mg PO or IV ... Antimicrobial #empiric #idsa ... #antibiotics #Bacterial ... Adults #management #pharmacology
IDSA Recommended Dosages of Antimicrobial Agents Administered by the Intraventricular Route
Amikacin - 5–50 mg
Amphotericin B -
IDSA Recommended ... 0.01–0.5 mg in 2 mL ... Intraventricular #antibiotics ... #dosing #pharmacology ... ventriculitis #table #idsa
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
IDSA Recommendations ... Castleman’s Disease (MCD ... valganciclovir or IV ... KaposiSarcoma #Castlemans #IDSA ... infections #HIVAIDS #pharmacology